A Comparison of Insulin Lispro MM Intensive Mixture Therapy With Progressive Dose-Titration of Insulin Lispro LM or Biphasic Insulin Aspart 30/70.
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2011
At a glance
- Drugs Insulin neutral protamine lispro/insulin lispro (Primary) ; Insulin aspart/insulin protamine aspart
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 27 Oct 2011 Results published in the Clinical Therapeutics.
- 25 Jun 2010 Results presented at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA 2010).
- 04 May 2010 Actual patient number amended from 275 to 302 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History